Association between eIF3α polymorphism and severe toxicity caused by platinum-based chemotherapy in non-small cell lung cancer patients

Journal article

Peer reviewed

Xiaojing Xu, Lifang Han, Li Duan, Ying-Chun Zhao, Huaping Yang, Honghao Zhou, Rui Ma, Ruixia Yuan and Zhaoqian Liu

British Journal of Clinical Pharmacology, Vol.75(2), pp.522-534

02/2013

Metrics

5 Record Views

Title: Association between eIF3α polymorphism and severe toxicity caused by platinum-based chemotherapy in non-small cell lung cancer patients
Creators: Xiaojing Xu (Author)
Lifang Han (Author)
Li Duan (Author)
Ying-Chun Zhao (Author) - Creighton University
Huaping Yang (Author)
Honghao Zhou (Author)
Rui Ma (Author)
Ruixia Yuan (Author)
Zhaoqian Liu (Author)
Publication Details: British Journal of Clinical Pharmacology, Vol.75(2), pp.522-534
Number of pages: 522-534
Identifiers: 991005930899402656
Academic Unit: School of Medicine; Endocrine
Resource Type: Journal article